Clinical validation of a quantitative systems pharmacology (QSP) model for nerve-growth factor (NGF) therapies Poster Clinical validation of a quantitative systems pharmacology (QSP) model for nerve-growth factor (NGF) therapies Certara2019 年 9 月 2 日
Mechanistic Physiologically-Based Pharmacokinetic Modelling for Prediction of Dermal Absorption in Psoriatic Patients Poster Mechanistic Physiologically-Based Pharmacokinetic Modelling for Prediction of Dermal Absorption in Psoriatic Patients Certara2019 年 9 月 2 日
A comprehensive and systematic review of gastric pH and factors affecting gastric fluid volume dynamics under fasted and fed conditions in healthy adults. 海报 A comprehensive and systematic review of gastric pH and factors affecting gastric fluid volume dynamics under fasted and fed conditions in healthy adults. Certara2019 年 9 月 2 日
Development of a Mechanistic Model for the PBP/TK Based Prediction of Tissue Exposure Following Inhalation Exposure Poster Development of a Mechanistic Model for the PBP/TK Based Prediction of Tissue Exposure Following Inhalation Exposure Certara2019 年 9 月 2 日
A new particle population balance model (PPB) for PBPK modelling of orally dosed drugs accounting for two solid states O Simcy Poster A new particle population balance model (PPB) for PBPK modelling of orally dosed drugs accounting for two solid states O Simcy Certara2019 年 9 月 2 日
Evaluation of Clinical DDI Potential of Methotrexate Using PBPK Modeling Poster Evaluation of Clinical DDI Potential of Methotrexate Using PBPK Modeling Certara2019 年 9 月 2 日
Application of PBPK modelling for prediction of tacrolimus exposure in CYP3A combined genotype groups (CYP3A4*22 and/or CYP3A5*3) and a renal transplant population Poster Application of PBPK modelling for prediction of tacrolimus exposure in CYP3A combined genotype groups (CYP3A4*22 and/or CYP3A5*3) and a renal transplant population Certara2019 年 9 月 2 日
Assessment of maternal and fetal dolutegravir exposure by integrating ex vivo placental perfusion data and physiologically-based pharmacokinetic modeling Poster Assessment of maternal and fetal dolutegravir exposure by integrating ex vivo placental perfusion data and physiologically-based pharmacokinetic modeling Certara2019 年 9 月 2 日
In Vitro to In Vivo Extrapolation of Valproic Acid Hepatotoxicity: a Biokinetic and Physiologically Based Toxicokinetic Informed Approach Poster In Vitro to In Vivo Extrapolation of Valproic Acid Hepatotoxicity: a Biokinetic and Physiologically Based Toxicokinetic Informed Approach Certara2019 年 9 月 2 日
Iterative Development of a Physiologically Based Pharmacokinetic Model for Valproic Acid and Reverse Translation of In Vitro Toxicity Data Poster Iterative Development of a Physiologically Based Pharmacokinetic Model for Valproic Acid and Reverse Translation of In Vitro Toxicity Data Certara2019 年 9 月 2 日
